0001201715-26-000007.txt : 20260319 0001201715-26-000007.hdr.sgml : 20260319 20260319170730 ACCESSION NUMBER: 0001201715-26-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260317 FILED AS OF DATE: 20260319 DATE AS OF CHANGE: 20260319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAKER G LEONARD JR CENTRAL INDEX KEY: 0001201715 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50679 FILM NUMBER: 26775138 MAIL ADDRESS: STREET 1: 755 PAGE MILL ROAD, SUITE A-200 CITY: PALO ALTO STATE: CA ZIP: 94304-1005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC CENTRAL INDEX KEY: 0001088856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 770487658 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 REDWOOD SHORES PARKWAY CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650.688.8803 MAIL ADDRESS: STREET 1: 101 REDWOOD SHORES PARKWAY CITY: REDWOOD CITY STATE: CA ZIP: 94065 4 1 form4-03192026_090326.xml X0609 4 2026-03-17 0001088856 CORCEPT THERAPEUTICS INC CORT 0001201715 BAKER G LEONARD JR 755 PAGE MILL ROAD SUITE A-200 PALO ALTO CA 94304-1005 true false false false 0 Common Stock 2026-03-17 4 P 0 75782 33.0022 A 1122413 D Common Stock 2026-03-17 4 P 0 24218 33.5633 A 1146631 D Common Stock 3308303 I By Ltd Partnership Common Stock 1095262 I By Trust The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $32.43 to $33.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $33.44 to $33.68 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust. /s/ Kanwalpreet S. Kalra, by power of attorney 2026-03-19